Polymyositis and dermatomyositis in adults. Tunisian multicentre study

被引:11
|
作者
Toumi, S. [1 ]
Ghnaya, H. [1 ]
Braham, A. [2 ]
Harrabi, I. [3 ]
Laouani-Kechrid, C. [1 ]
机构
[1] CHU Sahloul, Serv Med Interne, Sousse, Tunisia
[2] CHU La Rabta, Serv Med Interne, Tunis, Tunisia
[3] CHU Farhat Hached, Serv Epidemiol, Sousse, Tunisia
来源
REVUE DE MEDECINE INTERNE | 2009年 / 30卷 / 09期
关键词
Polymyositis; Dermatomyositis; Epidemiology; Interstitial lung disease; Malignancy; INTERSTITIAL LUNG-DISEASE; CLINICAL-FEATURES; INFLAMMATORY MYOPATHIES; CANCER; MALIGNANCY; PROGNOSIS; RISK; TERM;
D O I
10.1016/j.revmed.2009.03.356
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction. - To study the clinical features and the outcome of polymyositis (PM) and dermatomyositis (DM) in Tunisia. Methods. - Retrospective multicentre study conducted by the Tunisian Society of Internal Medicine. Adult patients with confirmed and probable PM and DM, according to the Bohan and Peter's criteria, were included in the study and followed-up between 1987 and 2005. Results. - Twenty cases of PM and 50 cases of DM were included. Female/male sex-ratio was 2.5. The mean age at diagnosis was 40.7 years. Muscle weakness concerned girdle muscles in 94.3% and pharyngeal muscles in 42.8% of the patients. Interstitial lung disease and heart involvement Occurred respectively in 35.7 and 20%. Eyelid erythema, peri-ungual erythema and Gottron's sign occurred in respectively 86, 50 and 36% of the cases of DM. Malignant disease was found in 12.8% of the patients (mainly gynecological and nasopharyngeal cancers). All patients received high dose corticosteroids with additional immunosuppressive drugs in 40% of the cases. The outcome was stabilization or partial improvement in 71.5% of the cases. Death occurred in 20% and was caused by respiratory failure, sepsis and cardiac failure. Conclusion. - The particularities of PM and DM in Tunisia are the preponderance of DM, early onset of the disease and high frequency of the nasopharyngeal cancer. (C) 2009 Published by Elsevier Masson SAS on behalf of the Societe nationale francaise de medecine interne (SNFMI).
引用
收藏
页码:747 / 753
页数:7
相关论文
共 50 条
  • [31] AN OVERVIEW OF POLYMYOSITIS AND DERMATOMYOSITIS
    Findlay, Andrew R.
    Goyal, Namita A.
    Mozaffar, Tahseen
    MUSCLE & NERVE, 2015, 51 (05) : 638 - 656
  • [32] Treatment of dermatomyositis and polymyositis
    Choy, EHS
    Isenberg, DA
    RHEUMATOLOGY, 2002, 41 (01) : 7 - 13
  • [33] ELECTROMYOGRAPHY IN POLYMYOSITIS AND DERMATOMYOSITIS
    FREDERICKS, EJ
    MUSCLE & NERVE, 1994, 17 (10) : 1235 - 1236
  • [34] Infections in polymyositis and in dermatomyositis
    Marie, Isabelle
    PRESSE MEDICALE, 2009, 38 (02): : 303 - 316
  • [35] Prognosis of polymyositis and dermatomyositis
    Hui, A. C. F.
    Wong, S. M.
    Leung, T.
    CLINICAL RHEUMATOLOGY, 2007, 26 (01) : 92 - 92
  • [36] NODULAR DERMATOMYOSITIS (POLYMYOSITIS)
    HASSIN, GB
    KAPLAN, L
    TRANSACTIONS OF THE AMERICAN NEUROLOGICAL ASSOCIATION, 1949, : 226 - 227
  • [37] SPECTRUM OF POLYMYOSITIS AND DERMATOMYOSITIS
    PEARSON, CM
    BOHAN, A
    MEDICAL CLINICS OF NORTH AMERICA, 1977, 61 (02) : 439 - 457
  • [38] POLYMYOSITIS DERMATOMYOSITIS - COMMENTARY
    SONTHEIMER, RD
    CLINICS IN DERMATOLOGY, 1988, 6 (02) : R9 - R10
  • [39] Treatment of polymyositis and dermatomyositis
    Chérin, P
    REVUE DE MEDECINE INTERNE, 2004, 25 : S22 - S25
  • [40] Prognosis of polymyositis and dermatomyositis
    A. C. F. Hui
    S. M. Wong
    T. Leung
    Clinical Rheumatology, 2007, 26 : 92 - 92